La Trobe Institute for Molecular Science
Australian research institute based at La Trobe University
The La Trobe Institute for Molecular Science (LIMS) is an Australian institute based at La Trobe University in Melbourne. It contains research groups in life sciences (biochemistry and genetics), physical sciences (chemistry and physics), and applied sciences (pharmacy) and teaches undergraduate and graduate courses in these areas through the School of Molecular Sciences. Established in 2009, the institute has been led by Professor Patrick Humbert since 2022.
It also contains two biotech companies: Hexima and AdAlta. The institute is housed in three buildings: LIMS1 and LIMS2 on La Trobe University's main campus in Bundoora, and the Applied Science building on the Bendigo campus.
Research
Research in the institute is organised into six strategic themes, each with an appointed leader who oversees research.
Cancer; research includes metastasis, cell crosstalk, anti-tumour immunity, and therapeutic resistance and sensitivity.
Infection and Immunity; research includes development of antibiotic, anti-inflammatory, and anti-autoimmune compounds.
Neurobiology; research includes Alzheimer's, Parkinson's, multiple sclerosis, and prions.
Molecular Design; research includes protein-drug interaction, molecular synthesis, and surface and material science.
Begin with the source’s own compact description: “La Trobe Institute for Molecular Science” is australian research institute based at La Trobe University. The dossier treats that line as a proposition to test through Trobe, Institute and Molecular, not as a finished interpretation.
Why this record matters
The phrase “australian research institute based at La Trobe University” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
Contemporary correspondence, administrative files and participant testimony can test how later narratives organized the event or institution. The source revision retrieved here is dated Aug 13, 2026. The linked authority identifier is Q24185456. The first chronological checks are 2009 and 2022.
Later summaries often reconcile disputed chronology or motive more neatly than the contemporary record permits. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Compare institutional narratives with records created by participants and affected communities. Dates and formal titles are useful anchors, but not substitutes for context.
- Event chronology
- Institutional context
- Locating named record creators
Contemporary correspondence, government or organizational records, oral histories and cited historical scholarship.
Three-step research path
- Establish the record: confirm the title “La Trobe Institute for Molecular Science”, its source revision and the description used here.
- Expand the search: follow La Trobe Institute for Molecular Science primary sources, La Trobe Institute for Molecular Science archive and Trobe research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “La Trobe Institute for Molecular Science”?
- Which voices are present, absent or mediated by the institution?
- Who created the surviving record, and for what administrative purpose?
Search terms from this dossier
This entry incorporates text from “La Trobe Institute for Molecular Science” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.